[General medicine management of superficial venous thrombosis of the lower limbs: A survey in Saône-et-Loire]

J Mal Vasc. 2016 Feb;41(1):12-7. doi: 10.1016/j.jmv.2015.10.005. Epub 2015 Nov 27.
[Article in French]

Abstract

Context: For a long time, superficial venous thrombosis (SVT) of the lower limbs was considered as benign. Due to lack of clear scientific evidence, its treatment was heterogeneous and even potentially deleterious. Since 2010, several major studies have highlighted the seriousness of SVT, and prophylactic doses of fondaparinux have proven their efficacy for this indication. While the French recommendations have not yet taken on board all this data, has practice already changed?

Aim: To describe in general practice the usual management of suspected SVT.

Methods: A descriptive cross-sectional study of general practitioners in Saône-et-Loire. Each doctor taking part was asked to note on a paper questionnaire the details of the last patient in whom they suspected SVT. Data collected included: clinical presentation, diagnostic and therapeutic management and follow-up of the patients.

Results: Between 01/01/2014 and 31/03/2014, 88 doctors out of 443 contacted (20%) completed the questionnaire. According to the information they provided, 36 physicians (40.9% [95% CI: 30.6-50.2]) searched for an associated pulmonary embolism. Eighty-two physicians (93.2% [95% CI: 87.9-98.4]) prescribed a venous compression ultrasound (CUS) exploration. Twelve etiological assessments were carried out (13.6% [95% CI: 6.5-20.8]) of which 6 (6.8%) appeared to be justified. 64 (72.7%) of the patients were given an anticoagulant therapy (heparin or fondaparinux), including 15 (17%) at a prophylactic dose and 49 (55.7%) at a curative dose. Forty-nine doctors (55.7% [95% CI: 45.3-66.1]) prescribed a CUS follow-up.

Conclusion: General practitioners seem to have adapted their diagnostic practices to the data highlighting the potential seriousness of SVT. The treatment they give, however, remains very variable and potentially deleterious, in particular due to a high rate of treatments given at curative doses.

Keywords: Attitudes and health practices; Attitudes et pratiques en santé; Connaissances; General practice; Knowledge; Médecine générale; Superficial venous thrombosis; Thrombose veineuse superficielle.

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Anticoagulants / therapeutic use*
  • Cross-Sectional Studies
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fondaparinux
  • France / epidemiology
  • General Practitioners / psychology
  • General Practitioners / statistics & numerical data*
  • Health Care Surveys
  • Heparin / therapeutic use*
  • Humans
  • Leg / blood supply*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Polysaccharides / therapeutic use*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Pulmonary Embolism / complications
  • Pulmonary Embolism / diagnosis
  • Risk Factors
  • Stockings, Compression
  • Surveys and Questionnaires
  • Ultrasonography, Doppler / statistics & numerical data
  • Venous Thrombosis / complications
  • Venous Thrombosis / diagnostic imaging
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / epidemiology

Substances

  • Anti-Inflammatory Agents
  • Anticoagulants
  • Fibrin Fibrinogen Degradation Products
  • Platelet Aggregation Inhibitors
  • Polysaccharides
  • fibrin fragment D
  • Heparin
  • Fondaparinux